With the Blue Mountain School Board having trouble conducting business due to a lingering vacancy and division among the current directors, a Schuylkill County judge tasked with filling ...

Before I discuss what I do like about Eli Lilly, it is important to also highlight the risks. Pharmaceutical companies without exception face the risk that medical compounds fail to deliver on their ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Lilly's obesity drug strength fuels record rally, Wall Street optimism Eli Lilly shares surged to a record high on Thursday, as sales of blockbuster weight-loss injections helped the drugmaker beat ...

Eli Lilly LLY is a dominant player in the cardiometabolic market, backed by a strong and expanding GLP-1 portfolio. Its GLP-1 lineup includes Mounjaro and Zepbound (tirzepatide injections) for type II ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

After a period of just 48 weeks, patients who took tirzepatide along with eloralintide, which is an experimental drug that targets amylin, a natural hormone, but not GLP-1, achieved considerably more ...

Novo Nordisk is rated Buy versus Hold for Eli Lilly, anchored by a compelling valuation discount to big pharma peers. NVO trades at ~11.2x 2027 earnings, a ~26% discount to peer median, despite ...

Eli Lilly dominates the weight loss drug market and is delivering explosive revenue growth. The company has a strong pipeline, too, which may broaden its weight loss portfolio in the coming years.

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. A phase 3 clinical trial for a new weight-loss drug funded by Eli Lilly ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. CEO Dave Ricks built Eli Lilly into the first pharma company to hit a $1 trillion market cap ...